Published: 12 April 2022
Author(s): Isabel Almeida, João Amorim, Carlos Vasconcelos
Issue: June 2022
Section: Commentary

The gastrointestinal (GI) tract is affected in up to 90% of patients with systemic sclerosis (SSc). SSc is a key contributor to impairment and disability, leading to remarkable abnormal social functioning and impaired quality of life [1,2], and it is one of the leading causes of death in the past decades [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.